Holen Sie sich die Stockscreener-App
8.83
2.20%
0.19
Handel nachbörslich:
8.83
Schlusskurs vom Vortag:
$8.64
Offen:
$8.75
24-Stunden-Volumen:
95,204
Relative Volume:
0.87
Marktkapitalisierung:
$127.31M
Einnahmen:
$166.88M
Nettoeinkommen (Verlust:
$-74.18M
KGV:
-1.7416
EPS:
-5.07
Netto-Cashflow:
$1.14M
1W Leistung:
+8.88%
1M Leistung:
-19.73%
6M Leistung:
-50.56%
1J Leistung:
-65.43%
1-Tages-Spanne:
$8.75
$9.09
1-Wochen-Bereich:
$7.92
$9.25
52-Wochen-Spanne:
$7.8701
$26.99
Anika Therapeutics Inc Stock (ANIK) Company Profile
Firmenname
Anika Therapeutics Inc
Sektor
Telefon
(781) 457-9000
Adresse
32 WIGGINS AVENUE, BEDFORD, MA
Vergleichen Sie ANIK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
8.83 | 124.57M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
154.11 | 67.83B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.00 | 46.74B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.52B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.86 | 20.12B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
313.13 | 14.11B | 2.99B | 1.21B | 1.13B | 25.06 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-17 | Eingeleitet | B. Riley Securities | Buy |
| 2024-11-01 | Bestätigt | Barrington Research | Outperform |
| 2023-08-14 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2023-03-07 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2022-11-09 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-14 | Fortgesetzt | Stephens | Equal-Weight |
| 2022-03-09 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2022-03-09 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2021-11-16 | Eingeleitet | Stephens | Overweight |
| 2021-07-16 | Eingeleitet | UBS | Neutral |
| 2020-12-16 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-08 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-01-21 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-01-10 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-11-05 | Eingeleitet | BWS Financial | Sell |
| 2019-09-24 | Bestätigt | Barrington Research | Outperform |
| 2019-09-23 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Strong Buy |
| 2019-02-22 | Herabstufung | First Analysis Sec | Outperform → Neutral |
| 2019-02-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2018-07-27 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-06-20 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2018-06-20 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2018-05-04 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-02-23 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2018-01-24 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
| 2017-10-27 | Bestätigt | Barrington Research | Outperform |
| 2016-05-09 | Hochstufung | Singular Research | BUY - Long-Term → Buy |
| 2016-04-27 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2016-02-26 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Anika Therapeutics Inc Aktie (ANIK) Neueste Nachrichten
Chart overlay techniques for tracking Anika Therapeutics Inc.July 2025 Breakouts & Safe Swing Trade Setups - Newser
Price momentum metrics for Anika Therapeutics Inc. explainedJuly 2025 Levels & Verified Chart Pattern Trade Signals - Newser
ANIK ACTIVE INVESTIGATION: Lost Money on Anika Therapeutics, Inc.? Contact Levi & Korsinsky Now - ACCESS Newswire
Combining machine learning predictions for Anika Therapeutics Inc.July 2025 Opening Moves & Community Verified Watchlist Alerts - Newser
Should you buy the dip on Anika Therapeutics Inc.2025 Bull vs Bear & Trade Opportunity Analysis - classian.co.kr
How to track smart money flows in Anika Therapeutics Inc.July 2025 Fed Impact & AI Based Buy and Sell Signals - Newser
ANIK ALERT: Ongoing Investigation Into Anika Therapeutics, Inc.Contact Levi & Korsinsky - ACCESS Newswire
Published on: 2025-08-14 04:24:44 - Newser
Published on: 2025-08-14 03:22:26 - Newser
How Anika Therapeutics Inc. stock performs during market volatilityShort Setup & Daily Risk Controlled Trade Plans - Newser
Technical analysis overview for Anika Therapeutics Inc. stockEarnings Recap Summary & Daily Entry Point Alerts - Newser
Anika Therapeutics faces investigation over potential securities fraud claims. - AInvest
How to manage a losing position in Anika Therapeutics Inc.Earnings Growth Summary & Long-Term Safe Investment Plans - Newser
How to track smart money flows in Anika Therapeutics Inc. [2025 Trading Recap]Free Entry Point Confirmation Signals - Newser
Lost Money on Anika Therapeutics, Inc. (ANIK)? Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire
Can Anika Therapeutics Inc. hit a new high this monthFree Real Time Alerts Based on AI Prediction - Newser
Applying big data sentiment scoring on Anika Therapeutics Inc.2025 Key Lessons & Low Risk High Win Rate Stock Picks - Newser
ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Anika Therapeutics - Bluefield Daily Telegraph
ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. Continues - GlobeNewswire
ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Ongoing Anika Therapeutics, Inc. (ANIK) Investigation: Protect Your RightsContact Levi & Korsinsky - ACCESS Newswire
Lost Money on Anika Therapeutics, Inc. (ANIK)? Contact Levi & Korsinsky About Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc.ANIK - PR Newswire
What makes Anika Therapeutics Inc. stock price move sharplyAI Triggered Buy Zone Forecast System - Newser
Applying chart zones and confluence areas to Anika Therapeutics Inc.Free Accurate Technical Trend Reversal Picks - Newser
Why Anika Therapeutics Inc. stock attracts strong analyst attentionROI Focused Watchlist with Trade Confidence - Newser
Tools to assess Anika Therapeutics Inc.’s risk profileHigh Return Trade Roadmap with Setup Filters - Newser
Ongoing Securities Investigation into Anika Therapeutics, Inc. (ANIK)Contact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Launches Fraud Investigation on Behalf of Anika Therapeutics, Inc. (ANIK) Shareholders - ACCESS Newswire
What’s the recovery path for long term holders of Anika Therapeutics Inc.Risk Managed Watchlist with Breakout Picks - Newser
Anika Therapeutics Inc. stock momentum explainedFree Buy Signal Based on Chart Analysis - Newser
Anika Therapeutics shares rise 2.77% after-hours following positive clinical trial results for Hyalofast. - AInvest
ATTENTION ANIK Shareholders: Lost Money on Anika Therapeutics, Inc.? Contact Levi & Korsinsky About Investigation - ACCESS Newswire
Anika Therapeutics: Undervalued HA Platform with 2027 Catalysts - AInvest
Anika Therapeutics: Undervalued HA Platform With 2027 Catalysts (ANIK) - Seeking Alpha
Anika Therapeutics Inc. stock volume spike explainedFree Investment Strategy With Low Risk - Newser
Levi & Korsinsky Investigates Anika Therapeutics, Inc. (ANIK) Over Possible Securities Fraud - ACCESS Newswire
Anika Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Anika Therapeutics, Inc. (ANIK) - ACCESS Newswire
Revenues Working Against Anika Therapeutics, Inc.'s (NASDAQ:ANIK) Share Price Following 26% Dive - simplywall.st
Published on: 2025-08-05 23:20:00 - Newser
Finanzdaten der Anika Therapeutics Inc-Aktie (ANIK)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.80%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):